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Abstract 
In this paper, we demonstrate the preparation of silibinin-loaded carbon nanotubes (SWSB) with surface coating 
agents via non-covalent approach as an effective drug delivery system. The resulting surface-coated SWSB nano-
composites are extensively characterized by Fourier transform infrared (FTIR) and Raman spectroscopies, ultravio-
let–visible (UV–Vis) spectrometry and field emission scanning electron microscopy (FESEM). The FTIR and Raman 
studies show that an additional layer is formed by these coating agents in the prepared nanocomposites during the 
coating treatment and these results are confirmed by FESEM. Drug loading and release profiles of the coated SWSB 
nanocomposites in phosphate buffered saline solution at pH 7.4 is evaluated by UV–Vis spectrometry. The in vitro 
results indicate that the surface-modified nanocomposites, with SB loading of 45 wt%, altered the initial burst and 
thus, resulted in a more prolonged and sustained release of SB. In addition, these nanocomposites exhibit a pseudo-
second-order release kinetic which was driven by the ion exchange between the ionized SWSB and the anions in the 
release medium. The cytotoxicity effect of the resulting nanocomposites on normal mouse fibroblast cells is evalu-
ated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. It is observed that the surfactant 
and polymer coating improved the biocompatibility of the SWSB nanocomposites significantly, which deem further 
exploitation for their application as potential anticancer drug delivery system.
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Background
Cancer, a common name given to a group of related ill-
nesses, has a great impact on public health across the 
world. In the United States, cancer is the second leading 
cause of death after heart disease, accounting for nearly 1 
of every 4 deaths [1]. According to the source which was 
published recently, American men have a slightly higher 
risk for developing cancer (less than 1 in 2) compared 
to women (a little more than 1 in 3) over the course of 
their lifetimes. These figures reveal that, cancer rates are 
growing at an alarming speed and it is expected to rise by 
57% globally in the next 20 years, as predicted by World 
Health Organization [2].
Chemotherapy is the drug treatment for cancer dis-
ease using powerful chemicals, and it is expected to kill 
the cancer cells for maximum treatment efficacy without 
destroying other normal cells in the body. However, many 
of the conventional chemotherapies are often associated 
with drug administration problems like lack of selectiv-
ity, limited solubility, poor distribution, systemic toxicity 
and the inability of drugs to cross cellular barriers. There-
fore, it is essentially important for medicinal chemists to 
alter the drug actions by developing a well-designed drug 
delivery system with specific tumour-targeting and pH-
triggered unloading properties, while reducing unwanted 
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side effects (e.g. fatigue, nerve damage, nausea, hair loss, 
skin and nail changes, heart trouble, and etc.) which can 
lead to serious complications.
In the recent years, silibinin (SB) has received a great 
amount of attention as herbal remedy to treat cancer-
related diseases. It has demonstrated potential clinical 
applications in the treatment of neurodegenerative and 
neurotoxic related diseases, diabetes mellitus, Amanita 
mushroom poisoning, several types of nephrotoxicity, 
alcoholic liver cirrhosis and various forms of in vitro and 
in  vivo cancer models [3–6]. SB, as the main constitu-
ent of silymarin, is obtained from the medicinal plant 
silybum marianum (milk thistle) and has been used for 
centuries to treat liver disorders due to its potent hepato-
protective effect [7]. However, its low solubility in aque-
ous environment which leads to poor bioavailability in 
the human body, has limited its clinical potential in bio-
medical applications.
Carbon nanomaterials such as carbon nanotubes have 
been extensively researched as a carrier for antican-
cer drugs [8], as they are capable of penetrating cellular 
membranes [9] and allow for high drug loading [10] due 
to their unique architectural features (e.g. high aspect 
ratio and nanoscale dimensions). They have the poten-
tial to deliver therapeutic molecules to the targeted site 
of action by conjugation to ligands of cancer cell surface 
receptors or antigens [11], which makes them an ideal 
delivery system to treat cancer diseases at the cellular 
level. In addition, they can be covalently or non-cova-
lently functionalized with hydrophilic materials such as 
polysorbate surfactant and polyethylene glycol (PEG) [12, 
13], to improve their biocompatibility and dispersability 
in physiological environment.
Previously, we have reported the preparation of SB-
loaded nanohybrid based on carboxylic acid functional-
ized single walled carbon nanotubes (SWCNT-COOH) 
[14]. Our preliminary findings showed that the system, 
with low toxicity, significantly suppressed the growth of 
human cancer cell lines, in particular, human lung cancer 
cells (A549) when compared to pure SB. Furthermore, 
the system possess favourable sustained release charac-
teristic and the release rate is pH-dependent which fur-
ther justify its potential to be developed into novel drug 
delivery system for cancer treatment. In this work, as an 
attempt to further improve the system’s biocompatibility, 
we have designed and prepared a new type of drug deliv-
ery system involved the use of surface-modified SWCNT 
for water-insoluble anticancer drug, SB. Biocompatible 
surface coating agents, namely polysorbate 20 (T20), pol-
ysorbate 80 (T80), PEG and chitosan (CS) were used to 
non-covalently wrapped around the SB-loaded SWNTs 
(SWSB), imparting water-solubility and biocompatibility 
to the nanotubes.
Normal mouse fibroblast cells (3T3) were employed to 
be comparable to the existing peer-reviewed literature 
since a vast number of papers suggest that carbon nano-
tubes possess a potential toxicological effect [15–17] but 
little is known about the cytotoxicity of drug-loaded car-
bon nanotubes, particularly of SWCNT form. In general, 
fibroblasts are the most versatile of connective-tissue 
cells and form supporting framework (stroma) of tis-
sues through their secretion of extracellular matrix com-
ponents which consists of ground substance and fibres 
[18]. Besides, these connective tissues play a critical role 
in wound healing and fibrosis, sharing some similarities 
with cancer-associated fibroblasts that are present within 
the tumour stroma of many cancers [19]. For this pur-
pose, the biocompatibility and cytotoxicity characteristic 
of surface-coated SWSB in fibroblasts were investigated 
by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay under in vitro environments.
Experimental
Materials
The SWCNT-COOH of purity 90 wt% (impurities:  <5% 
metal oxide as determined by TGA) and produced by the 
method of chemical vapour deposition, was purchased 
from Chengdu Organic Chemicals Co., Ltd. (Chengdu, 
China). They consist of short carboxyl carbon nano-
tubes with a diameter of 1–2 nm and a length of 1–3 μm 
(thus, aspect ratio  >1000) and the COOH content was 
found to be around 2.73 wt%. The SB (≥98% purity, 
482.44  g  mol−1) and ethanol (>99.8% purity) were pur-
chased from Sigma-Aldrich (Buchs, Switzerland) and the 
latter was used as solvent for SB. The T20 (polyethylene 
glycol sorbitan monolaurate, C58H114O26), T80 (polyeth-
ylene glycol sorbitan monooleate, C64H124O26), CS (low 
molecular weight, 75–85% degree of acetylation) and 
phosphate buffered saline (PBS) solution were sourced 
from Sigma-Aldrich (Saint Louis, USA). PEG (average 
molecular weight 300) was supplied by Acros Organics 
(Geel, Belgium). Acetic acid (99.8% purity) was obtained 
from HmbG Chemicals (Hamburg, Germany) and used 
as solvent for CS. All materials were analytical reagent 
grade and used without further purification.
Instruments
Fourier transform infrared (FTIR) measurements were 
performed on a Thermo Nicolet Nexus 671 (model Smart 
Orbit). The FTIR spectra of the samples were recorded in 
the scanning range of 400–4000 cm−1 with 32 scans at a 
resolution of 2 cm−1 using KBr disc method, except for 
pure T20 and T80 via a direct deposition method. Raman 
spectra were collected using a WITec UHTS 300 Raman 
spectrometer with an excitation wavelength at 532  nm 
and detailed scans were performed in the range of 
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100–3000 cm−1. UV–Vis spectra were used to study the 
optical property of the samples in a drug release experi-
ment, using a Perkin Elmer Lambda 35 spectrophotom-
eter. Thermogravimetric analysis (TGA) was carried out 
using a TA Q500 with a heating rate of 10 °C min−1 under 
a nitrogen purge of 40  mL  min−1 in the temperature 
range of 30–900  °C. The coating content was calculated 
to be about 19.3, 56.4, 15.7 and 4.6 wt% for T20, T80, 
PEG and CS respectively, based on the comparison of 
coated samples with the uncoated ones [20]. The surface 
morphology of the samples was captured on a Hitachi 
UHR SU8030 FESEM at 10 kV.
Preparation of carbon nanotubes‑silibinin formulation 
(SWSB)
The solution of SB was prepared according to the method 
described by our previous report [14]. It is noted that 
the best-fit linearity was obtained in the range of 0.003–
0.05 mg mL−1 in ethanol and thus, maximum dosage of 
SB at 0.05 mg mL−1 was selected in the study. Approxi-
mately 400  mg of SWCNT-COOH (as the starting 
material) was incubated in 400  mL of SB solution and 
sonicated in a water bath for 1 h in order to separate the 
nanotubes. Subsequently, the pH of the suspension was 
slowly adjusted to 4 to facilitate SB uptake. The suspen-
sion was then magnetically stirred at room temperature 
for about 20  h and followed by a centrifugation step at 
4000  rpm for 15  min. After discarding the supernatant, 
the nanotubes were washed three times with ethanol and 
deionized water in order to remove excessive unbound 
SB. Finally, the product was dried in an oven at 60 °C for 
24 h to obtain SWSB.
Preparation of the surface‑coated SWSB nanocomposites
The surface-coated SWSB was synthesized by adding 
100  mg of SWSB into 100  mL of deionized water con-
taining 1% T20, T80, PEG or 0.5% CS (v/v) and magneti-
cally stirred for 24 h at room temperature. After that, the 
reaction mixture was then collected, centrifuged and 
rinsed with deionized water three times. Finally, the 
black precipitate was left to dry completely in an oven to 
yield SWSB-T20, SWSB-T80, SWSB-PEG or SWSB-CS 
nanocomposites.
Drug loading and releasing
The amount of SB loaded into the SWCNT-COOH was 
determined by measuring the absorbance at 288 nm rela-
tive to a calibration curve based on the wt% of the ini-
tial drug to the unbound drug in the supernatant using 
a UV–Vis spectrophotometer. The drug loading capacity 
of SWCNT-COOH with SB was calculated to be around 
45 wt%. Orally administered SB is known to demon-
strate low oral bioavailability of 30–50% due to rapid 
metabolism of the first-pass effect to form conjugates 
such as glucuronide and sulfate which may not have the 
same biological activities as the parent compound [21, 
22]. Since the loading of SB in the prepared carbon nano-
tubes was within the bioavailability range of the drug and 
hence, this concentration (about 45 wt% of loaded SB) 
was used throughout the study.
To examine the drug release behaviour, 1  mg of sur-
face-coated SWSB was dispersed in 3.5 mL of PBS release 
media at pH 7.4 (simulating human body physiological 
condition). The temperature inside the UV–Vis machine 
was found to be approximately  ±35  °C. The release 
amount of SB was recorded at predetermined time inter-
vals and the release data was then fitted into five kinetic 
mathematical equations (i.e. zero order, pseudo-first 
order, pseudo-second order, Higuchi and Korsmeyer-
Peppas models).
Cell culture conditions
Cytotoxicity experiments were performed on the normal 
mouse fibroblast cell line 3T3 (ATCC, Manassas, USA). 
The cells were maintained as monolayers in plastic flasks 
in DMEM supplemented with 10% fetal bovine serum, 
15  mmol L−1 l-glutamine, 100 units  mL−1 penicillin, 
and 100  g  mL−1 streptomycin and grown in a humidi-
fied incubator with 5% CO2 at 37  °C. Confluent cells 
were trypsinized in a trypsin/EDTA solution and subse-
quently seeded into a 96-well plate containing 1  ×  105 
cells mL−1 and kept overnight for cell attachment. For 
treatment purpose, old media were discarded and new 
culture medium (controls) or culture medium contain-
ing different concentrations of surface-coated SWSB was 
added to the wells for 24  h. Suspensions of the coated 
samples were freshly prepared in PBS medium. Prior to 
the cytotoxicity experiment, the stock suspension was 
ultrasonicated in 10 s sequential steps for a total time of 
30  s in order to reduce agglomeration. The suspensions 
were prepared by diluting to the desired concentrations 
of 3.125, 6.25, 12.5, 25, 50, 75, and 100 μg mL−1.
MTT cytotoxicity assay
The MTT assay, which converts viable cells with active 
metabolism into a purple coloured formazan, was used 
to measure cell viability in 3T3 cell line. After culturing 
overnight, the cells were treated with different concentra-
tions of SWSB-T20, SWSB-T80, SWSB-PEG and SWSB-
CS in freshly prepared PBS medium and the plates were 
incubated at 37 °C in a 5% CO2 humidified incubator for 
72 h. Following incubation, 20 μL of MTT was added to 
each well and the plates were incubated for another 3 h. 
Subsequently, the solution in each well containing exces-
sive MTT and dead cells was discarded, and 100 μL of 
detergent reagent (dimethyl sulfoxide) was then added 
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to the cells to stop the conversion and solubilize the 
formazan. The quantity of formazan formed is directly 
proportional to the number of viable cells after the treat-
ment. The absorbance was measured at 570 nm using a 
microplate reader (Model EL 800X), with 630 nm as ref-
erence wavelength and the obtained data were averaged 
and fitted to Eq.  1, to determine the percentage of cell 
viability. The cells cultured without nanotubes were used 
as control. The experiment was performed in triplicate, 
and the result was expressed as the percentage of cell via-
bility with respect to control cells.
where OD = optical density.
Statistical analysis
Cytotoxicity data in 3T3 cells were obtained from inde-
pendent experiments with n = 3 for each data point. All 
data were expressed as the mean and standard deviation 
(±SD) and compared by one-way analysis of variance 
(ANOVA) and t-tests using SPSS version 20.0 software.
Results and discussions
Fourier transform infrared
The characteristic bands of SWCNT-COOH, SB and the 
final product, SWSB (Fig. 1a) have been discussed in our 
previous paper and therefore, in this work the emphasis 
is being placed on the surface-coated SWSB nanocom-
posites. The FTIR spectrum of pure T20 in Fig. 1b dem-
onstrated two strong bands at 2919 and 2858 cm−1 that 
could be due to the asymmetric and symmetric C–H 
stretching vibrations of the methylene (CH2) group [23]. 
The absorption bands at 1458 and 1350 cm−1 are attrib-
uted to the asymmetric and symmetric C–H bending 
vibrations of the methyl (CH3) structural unit in the T20 
[24]. The other characteristic bands occurred at 3486 
and 1734 cm−1 are assigned to the O–H vibration of the 
hydroxyl group or adsorbed water and C=O stretch-
ing of the ester group, respectively. All these peaks were 
seen to be shifted to lower wavenumber in the SWSB-
T20 nanocomposite (Fig.  1c), which show that signifi-
cant interaction has taken place between T20 and SWSB. 
Since the chemical structure of T80 (Fig. 1d) is similar to 
that of T20, the relative intensities of those characteris-
tic absorption bands are also observed in the SWSB-T80 
nanocomposite (Fig. 1e).
Figure 1f and g are the FTIR spectra of pure PEG and 
SWSB-PEG, respectively. The FTIR spectrum of PEG 
(Fig.  1f ) demonstrates that the most intense absorption 
band at 1104 cm−1 is due to the functional group of car-
bon oxygen (C–O) single bond of primary alcohol. The 
(1)
Cell viability (%) = (ODtreatment −ODmedium)/
(ODcontrol −ODmedium) × 100
peaks occurred at 3442, 1344 and 529 cm−1 are attributed 
to the O–H stretching vibrations, while the absorptions 
observed in the region 961 and 842  cm−1 correspond 
to the C–C–O asymmetric stretch and C–C–O sym-
metric stretch, respectively. Also, the IR peaks at 2888 
and 1470 cm−1 are due to the C–H stretching and bend-
ing vibrations in PEG [25]. For the case of SWSB-PEG 
(Fig. 1g), some of the bands disappeared, and the others 
were shifted to the lower frequency due to the chemical 
interaction between the PEG and SWSB. For example, 
the peak at 529  cm−1 due to the O–H vibration disap-
peared, and in addition, two new peaks were formed at 
1451 and 1388 cm−1 which are assigned to the CH2 bend-
ing and COO− symmetric stretch, respectively.
The FTIR spectrum of pure CS (Fig.  1h) presents a 
strong band at 3444 cm−1 indicative of asymmetric NH2 
and O–H stretching vibration, while absorption bands at 
2925, 1420 and 1384 cm−1 are due to typical C-H bond 
in –CH2 and –CH3 symmetrical deformation mode, 
respectively. The sharp band occurred at 1640  cm−1 is 
related to the characteristic of carbonyl bonds (C=O) of 
the amide group and the band at 1091 cm−1 corresponds 
to the stretching vibrations of C–O from C–O–C bonds 
[26]. In the spectrum of SWSB-CS (Fig. 1i), most of the 
bands are belong to CS functional groups and the –OH 
stretching frequency was seen to be shifted from 3444 to 
3438 cm−1. This could be due to the ionic π bonds inter-
action between the CS and the nanotubes, which is con-
sistent with previous report [27].
Raman
The Raman spectra of surface-coated SWSB are shown 
in Fig. 2c–f, while the Raman spectra of SWCNT-COOH 
and uncoated SWSB have also been included in Fig. 2a, 
b for the purpose of comparison. There are three dis-
tinct bands to be observed in the Raman spectrum of 
SWCNT-COOH. The presence of the R-band (radial 
breathing mode) in the low frequency range between 100 
and 300 cm−1 is dependent upon the tube diameter and 
this region varies with different samples. In the first order 
band region, two Raman bands are observed: the band 
occurred at 1342  cm−1 is generally known as the disor-
der-induced D-band and a higher intensity band centered 
at 1575 cm−1 is often called the tangential G-band. The 
D-band is correlated with structural defects and disor-
der present in the graphitic sp2 carbon systems, whereas 
G-band is closely related to the planar vibrational mode 
of sp2-bonded carbon atoms on the graphitic surface 
of the nanotubes [28]. The second order G’-band near 
2650 cm−1, which appears in the phonon spectra of sp2 
carbon-based materials, corresponds to the overtone of 
the D-band. It is observed that the Raman spectra are 
very similar for all samples (Fig.  2a–f), suggesting that 
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the nanotubes structure remains unmodified by the coat-
ing treatment of the polymers.
The degree of functionalization and imperfections 
can be estimated by measuring the intensity ratio (ID/
IG) of the D and G-band of the nanotubes [12]. The 
positions of D and G-bands as well as ID/IG ratios for 
all samples are listed in Table  1. It is found that the ID/
IG ratio increases after functionalization with SB, and as 
expected, this value was seen to be decreased gradually 
after coating treatment. However, this is not the case for 
CS-coated SWSB. This could be possibly due to the little 
amount of CS used in the present study which resulted 
in promoting more defects on the surface of the nano-
tubes when compared to the others. On the other hand, 
it is observed that the Tween series have slightly lower 
defect concentrations, indicating that both T20 and T80 
have the best surface wrapping on SWSB. Furthermore, 
it is worth to be noted that, the intensity ratio of ID/IG 
changes slightly from 0.550 for SWSB to 0.231–0.602 
for coated samples, suggesting that the coating process 
occurred through a non-covalent interaction. This is 
because a covalent functionalization would have signifi-
cantly increased the ID/IG ratio to >1 [29].
Field emission scanning electron microscope (FESEM)
FESEM has been used to study the surface morphology 
of the surface-coated SWSB nanocomposites (Fig. 3b–e), 
with SWCNT-COOH used as the comparison (Fig.  3a). 
SWCNT-COOH was seen to be appeared in bundles due 
to van der Waals interaction with smooth tubular surface 
Polyethylene glycol
Tween 20





















































































































































































































Fig. 1 FTIR spectra of (a) SWSB, (b) T20, (c) T20-coated SWSB, (d) T80, (e) T80-coated SWSB, (f) PEG, (g) PEG-coated SWSB, (h) CS and (i) CS-coated 
SWSB along with their chemical structures
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structure. After coating of the SWSB with polymers, 
the surface morphologies of the nanotubes were signifi-
cantly different from the starting material. Therefore, we 
inferred that the polymers assist in the dispersion and 
wrapping of the SWSB by covering most of the surface 
defects of the nanotubes and hence, a more compact 
structure of nanocomposites was observed. (e)
Drug release behaviour at pH 7.4
In our previous work, we have demonstrated that the 
system (SWSB) released SB in a pH-dependent fashion, 
with the maximum release of approximately 84% in pH 
7.4 as compared to 56% in pH 4.8. However, at the begin-
ning stage of the drug release, we observed a fast release 
near to 47% after 60 min and then followed by a slower 
step of sustained release up to 1300 min. As an attempt to 
reduce the initial burst, we have coated the system sepa-
rately with different types of polymers and then study the 
coating effect on the drug release behaviour in PBS solu-
tion at pH 7.4. Figure 4 illustrated the release profiles of 
SB from the surface-coated SWSB nanocomposites, with 
SB loading of 45%, based on the UV–Vis measurement. 
After the coating process, the release rate of SB from 
the coated nanocomposites (Fig. 4b–e) was significantly 
lower than the release rate of SB from the uncoated ones 
(Fig.  4a), with the amount of initial release reduced to 
approximately 6–17% after 60  min. This is because the 
surface coating molecules formed an additional layer by 
wrapping around the nanotubes [30], providing extra 
protection to the encapsulated SB from instant release 
at pH 7.4 environment and as a result, the release rate 
of SB was reduced. Due to the presence of the coating 
agents, the release of SB from coated samples could still 
be observed even after 3500  min with a slow and sus-
tained release characteristic. As SB is a drug character-
ized by its relatively short elimination half-life of 4–6  h 
[31] due to poor absorption in the body, hence, the slow 
and sustained release behaviour of SB with a release time 
of more than 48  h may greatly benefit the anticancer 
treatment.
It is observed that the release behaviour of SB from the 
surface-coated systems follows a specific order of SWSB-
PEG > SWSB-T80 > SWSB-CS > SWSB-T20, as demon-
strated in Fig. 4b–e. Among the systems, SWSB-PEG was 
found to exhibit the highest release rate due to the hydro-
philic nature of the PEG molecules which enhances the 
solubility of hydrophobic carriers (e.g. SWCNT-COOH) 
and drugs (e.g. SB) in aqueous environment, as a result of 
the steric hindrance [32]. Interestingly, remarkable differ-
ences were also noted in the release behaviour of SB from 
the nanocomposites coated by Tween surfactants. For 
example, SWSB-T80 demonstrated a higher release rate 
of 91% compared to the release rate of 58% from SWSB-
T20 at the end of the experiment. This is because partial 
hydrolysis of ester groups occurred at pH 7.4 which causes 
the polymeric chains in T20 and T80 underwent ioniza-
tion, thereby producing more charged –COO− groups. 
The polymeric systems would then encounter different 



































Fig. 2 Raman spectra of (a) SWCNT-COOH, (b) SWSB, (c) SWSB-T20, 
(d) SWSB-T80, (e) SWSB-PEG and (f) SWSB-CS nanocomposites
Table 1 Peak positions of  D and  G-bands as  well as  ID/
IG ratios for  SWCNT-COOH, SWSB and  the surface-coated 
nanocomposites
Sample D‑band (cm−1) G‑band (cm−1) Intensity ratio 
(ID/IG)
SWCNT-COOH 1342 1575 0.273
SWSB 1338 1575 0.550
SWSB-T20 1346 1579 0.231
SWSB-T80 1346 1579 0.241
SWSB-PEG 1342 1579 0.434
SWSB-CS 1342 1579 0.602
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extent of swelling due to the repulsion forces between the 
ionized carboxyl groups [33], thus causing the drug mol-
ecules to be diffused through water-filled outermost layer 
at a different rate. As for the SWSB-CS, the released SB 
from the system was nearly 73%, even though it has the 
least coating content of 4.6 wt% as measured by TGA 
analysis. Under the neutral environment (pH  7.4), the 
hydrophilic carboxyl groups from SWCNT-COOH will 
Fig. 3 FESEM images of (a) SWCNT-COOH, (b) SWSB-T20, (c) SWSB-T80, (d) SWSB-PEG and (e) SWSB-CS at magnification 100 k×
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be ionized [34], facilitating the release of SB from the sur-
face of nanotubes into the CS thin coating. As a result, 
the CS polymer swelled causing a constant slow diffusion 
of SB molecules into the PBS medium. The in vitro drug 
release experiments showed that the drug release behav-
iour can be altered by using various selections of biocom-
patible polymers to suit different therapeutic applications.
Drug release kinetics and possible mechanisms
To study the release kinetics of SB, data obtained from 
in  vitro drug release experiments (Fig.  4) can be fitted 
into five different mathematical kinetic models [35, 36] as 
shown in Table 2.
Based on the release kinetics data listed in Table 2, the 
pseudo-second-order kinetic model with the best linear 
fit was found to be more appropriate for depicting the 
release kinetic processes of SB from the surface-coated 
nanocomposites (Fig. 5). This indicates that the rate lim-
iting step may be chemisorption involving the exchange 
of electrons between the surface-coated SWSB and the 
anions in the PBS medium at time of release and that 
released at equilibrium.
Effects of surface‑coated SWSB on cell viability
Most cytotoxicity research in the literature has used the 
concentration range of carbon nanotubes between 0.1 
and 200 μg mL−1 with maximum incubation up to 96 h 
on different types of normal cell lines [37–40]. This is 
because carbon nanotubes is generally associated with a 
concentration- and time-dependent increase in cell death 
as investigated by the use of the MTT assay. Therefore, 
in the present work, healthy 3T3 fibroblast cell line was 
used to treat with various doses ranging from 3.125 to 
100  μg  mL−1 of surface-coated SWSB for 72  h and the 
effect of polymer coatings on cell viability was evaluated 
by MTT assay (Fig. 6).
Although a vast number of studies have demonstrated 
that the surfactants and polymers are non-toxic, as they are 
capable of enhancing dispersibility to promote biocompat-
ibility, still, it is essential to investigate the effect of the con-
jugation on healthy cells. The cytotoxicity results showed 
that the coating agents have tremendously improved the 
biocompatibility of SWSB nanocomposites in comparison 
with our previous findings [14], in which the non-coated 
compounds demonstrated cytotoxicity when the concen-
tration exceeded 25  μg  mL−1. In particular, the uncoated 
SWSB at concentration of 50 μg mL−1 showed 20.6% viabil-
ity, whereas the coated SWSB showed 69.3, 66.2, 73.9 and 

































Fig. 4 Release profiles of SB from (A) SWCNT-COOH, (B) SWSB-PEG, 
(C) SWSB-T80, (D) SWSB-CS and (E) SWSB-T20 at pH 7.4 with maxi-
mum release rate of 84, 99, 91, 73 and 58% respectively. Inset shows 
the initial release of the nanocomposites at pH 7.4 in the first 100 min
Table 2 Linear regression analysis (R2) of  samples 
and their corresponding overall mean percent error (MPE) 
obtained by  fitting the SB release data from  biocompat-
ible surface-coated SWSB nanocomposites into  PBS solu-
tion at pH 7.4
a Release of SB was limited to 1300 min. qt, qe and q∞ refer to the amount of 
drug released at time (t), at equilibrium and at infinite time. k0, k1, k2 and kH are 
rate constant of the models
Model name Equation Sample R2 MPE
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√
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a SWSB b SWSB-T20
c SWSB-T80 d SWSB-PEG
e SWSB-CS
Fig. 5 Fits of the release data of SB from (a) SWSB, (b) SWSB-T20, (c) SWSB-T80, (d) SWSB-PEG and (e) SWSB-CS at pH 7.4 using pseudo-second-
order kinetic model
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77.3% viability for T20, T80, PEG, and CS, respectively. 
However, it was seen that the surface-coated SWSB nano-
composites demonstrated a gradual decrease in the cell 
viability as the concentration increases, with the lowest cell 
viability of 54.7% observed in SWSB-PEG at concentration 
of 100  μg  mL−1. The low viability of PEG-coated SWSB 
could be attributed to the toxic substances (i.e. monomer, 
dimer, and trimer), impurities (e.g. fatty acids, catalyst resi-
due, ethylene oxide) and by-product (e.g. 1,4-dioxane) pre-
sent in the low-molecular-weight glycol used in this study 
[41–43]. These in vitro results reveal that the surface coat-
ing agents expressed different level of cytotoxic effects to 
the normal mouse fibroblast cells and therefore, further 
investigation in terms of specific cellular mechanism is 
deem necessary in order to elucidate the mode of interac-
tions with normal human fibroblasts and cancer-associated 
fibroblasts within different tumours.
Conclusions
We demonstrated the preparation of surface-coated 
SWSB nanocomposites through a simple non-cova-
lent method. In order to achieve better dispersion and 
improved biocompatibility, T20, T80, PEG and CS were 
used as a coating agent separately. FTIR and Raman stud-
ies confirmed the chemical interaction between the bio-
compatible polymers and SWSB. The release of SB from 
the surface-modified system occurs only after water pen-
etration in the polymeric outer layer, followed by diffu-
sion process to the surface of the system. Furthermore, 
the release of SB is correlated to the swelling character-
istics of the surfactants. Despite the structural similarity 
between T20 and T80, the mechanisms of release are dis-
tinctively different, with the higher release rate observed 
in SWSB-T80 (~91%) compared to SWSB-T20 (~58%). 
In addition, the released SB from the coated systems is 
described by pseudo-second-order release mechanism, 
and that the release fashion is a slow and sustained pro-
cess which may benefit the anticancer treatment sig-
nificantly. The in  vitro cytotoxicity study shows that 
the coating agents greatly enhanced the dispersibility 
and biocompatibility of the SWSB, with an increase of 
approximately 48.7% (SWSB-T20), 45.6% (SWSB-T80), 
53.3% (SWSB-PEG), and 56.7% (SWSB-CS) viability at 












SWSB-T20 SWSB-T80 SWSB-PEG SWSB-CS
*
*
Fig. 6 Cell viability of 3T3 cell line treated with SWSB-T20, SWSB-T80, SWSB-PEG, and SWSB-CS for 72 h. Cell viability is calculated as a percentage 
of absorbance of treated cells over absorbance of untreated cells. Data are shown as mean ± standard deviation from three separate experiments 
(n = 3). Asterisks indicate statistically significant differences of the cell viability between the concentrations (p < 0.05)
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with cell viability assays, it would be difficult to draw 
accurate and reliable conclusions as these nanotubes 
might potentially interfere with viability markers in the 
assay systems, leading to a false positive or false negative 
result of cell viability. As such, several different spectro-
photometric assays such as lactate dehydrogenase (LDH) 
leakage, water soluble tetrazolium salts (WST-1) and 
[2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazo-
lium-5-carboxanilide] (XTT) should be used in conjunc-
tion with MTT assay for this new class of nanomaterials. 
Nonetheless, this work is a good preparation for our fol-
lowing research on the in vitro cellular mechanism study 
to assess how they interact with cells.
Authors’ contributions
JMT carried out the synthesis and characterization of surface-coated SWSB 
nanocomposites and prepared the manuscript. GK and SAG helped to con-
duct the MTT assay and JMT analyzed the data. SF and MZH supervised the 
study and helped to review the manuscript. All authors read and approved 
the final manuscript.
Author details
1 Materials Synthesis and Characterization Laboratory, Institute of Advanced 
Technology (ITMA), Universiti Putra Malaysia, 43400 Serdang, Selangor, Malay-
sia. 2 Laboratory of Vaccine and Immunotherapeutics, Institute of Bioscience 
(IBS), Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia. 3 Depart-
ment of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti 
Putra Malaysia, 43400 Serdang, Selangor, Malaysia. 
Acknowledgements
The work was supported by the Ministry of Education of Malaysia (MOE) under 
grant No. GP-IPB/2013/9425800. We thank our colleague, Saifullah Bullo (Ph.D) 
for assistance with statistical analysis and insight that greatly improved the 
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 June 2016   Accepted: 1 December 2016
References
 1. American Cancer Society (2015) Cancer facts & figures 2015. American 
Cancer Society, Atlanta
 2. Stewart BW, Wild CP (2014) World Cancer Report 2014. International 
Agency for Research on Cancer, France
 3. Li F, Ma Z, Guan Z, Chen Y, Wu K, Guo P, Wang X, He D, Zeng J (2015) Autophagy 
induction by silibinin positively contributes to its anti-metastatic capacity via 
AMPK/mTOR pathway in renal cell carcinoma. Int J Mol Sci 16:8415–8429
 4. Narayanapillai S, Agarwal C, Deep G, Agarwal R (2014) Silibinin inhibits 
ultraviolet B radiation-induced DNA-damage and apoptosis by enhanc-
ing interleukin-12 expression in JB6 cells and SKH-1 hairless mouse skin. 
Mol Carcinog 53:471–479
 5. Ge Y, Zhang Y, Chen Y, Li Q, Chen J, Dong Y, Shi W (2011) Silibinin causes 
apoptosis and cell cycle arrest in some human pancreatic cancer cells. Int 
J Mol Sci 12:4861–4871
 6. Cheung CWY, Gibbons N, Johnson DW, Nicol DL (2010) Silibinin—a 
promising new treatment for cancer. Anticancer Agents Med Chem 
10:186–195
 7. Gazak R, Walterova D, Kren V (2007) Silybin and silymarin—new and 
emerging applications in medicine. Curr Med Chem 14:315–338
 8. Madani SY, Naderi N, Dissanayake O, Seifalian AM (2011) A new era 
of cancer treatment: carbon nanotubes as drug delivery tools. Int J 
Nanomed 6:2963–2979
 9. Park S, Shin J, Lee J, Cha M (2012) Manipulation of NIH3T3 cells with func-
tionalized single-walled carbon nanotubes under a magnetic field. Mater 
Lett 68:378–381
 10. Zheng X, Wang T, Jiang H, Li Y, Jiang T, Zhang J, Wang S (2013) Incorpora-
tion of carvedilol into PAMAM-functionalized MWNTs as a sustained drug 
delivery system for enhanced dissolution and drug-loading capacity. 
Asian J Pharm Sci 8:278–286
 11. Heister E, Neves V, Tîlmaciu C, Lipert K, Beltrán VS, Coley HM, Silva SRP, 
McFadden J (2009) Triple functionalization of single-walled carbon nano-
tubes with doxorubicin, a monoclonal antibody, and a fluorescent marker 
for targeted cancer therapy. Carbon 47:2152–2160
 12. Kaur P, Shin MS, Joshi A, Kaur N, Sharma N, Park JS, Sekhon SS 
(2013) Interactions between multiwall carbon nanotubes and 
poly(diallyldimethylammonium) chloride: effect of the presence of a 
surfactant. J Phys Chem B 117:3161–3166
 13. Heister E, Neves V, Lamprecht C, Silva SRP, Coley HM, McFadden J (2012) 
Drug loading, dispersion stability, and therapeutic efficacy in targeted 
drug delivery with carbon nanotubes. Carbon 50:622–632
 14. Tan JM, Karthivashan G, Arulselvan P, Fakurazi S, Hussein MZ (2014) In vitro 
nanodelivery of silibinin as an anticancer drug under pH response. J Drug 
Del Sci Tech 24:579–584
 15. Patlolla A, Knighten B, Tchounwou P (2010) Multi-walled carbon nano-
tubes induce cytotoxicity, genotoxicity and apoptosis in normal human 
dermal fibroblast cells. Ethn Dis 20(1 Suppl 1):S1
 16. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H (2006) Cytotoxicity 
of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 
20:1202–1212
 17. Shinde A, Tsai C (2015) Toxicity mechanism in fetal lung fibroblast cells 
for multi-walled carbon nanotubes defined by chemical impurities and 
dispersibility. Toxicol Res. doi:10.1039/C5TX00211G
 18. Gabbiani G, Ryan GB, Majne G (1971) Presence of modified fibroblasts in 
granulation tissue and their possible role in wound contraction. Experien-
tia 27(5):549–555
 19. Cirri P, Chiarugi P (2011) Cancer associated fibroblasts: the dark side of the 
coin. Am J Cancer Res 1(4):482–497
 20. Tan JM, Karthivashan G, Abd Gani S, Fakurazi S, Hussein MZ (2016) 
Biocompatible polymers coated on carboxylated nanotubes functional-
ized with betulinic acid for effective drug delivery. J Mater Sci Mater Med 
27:26
 21. Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC (2008) 
Pharmacokinetics and metabolic profile of free, conjugated, and total 
silymarin flavonolignans in human plasma after oral administration of 
milk thistle extract. Drug Metab Dispos 36:65–72
 22. Lorenz D, Lucker PW, Mennicke WH, Wetzelsberger N (1984) Pharmacoki-
netic studies with silymarin in human serum and bile. Methods Find Exp 
Clin Pharmacol 6:655–661
 23. Guo Z, Xiong J, Yang M, Xiong S, Chen J, Wu Y, Fan H, Sun L, Wang J, 
Wang H (2010) Dispersion of nano-TiN powder in aqueous media. J Alloy 
Compd 493:362–367
 24. Ratanajiajaroen P, Watthanaphanit A, Tamura H, Tokura S, Rujiravanit R 
(2012) Release characteristic and stability of curcumin incorporated in 
β–chitin non-woven fibrous sheet using Tween 20 as an emulsifier. Eur 
Polym J 48:512–523
 25. Shameli K, Ahmad M, Jazayeri SD, Sedaghat S, Shabanzadeh P, Jahang-
irian H, Mahdavi M, Abdollahi Y (2012) Synthesis and characterization of 
polyethylene glycol mediated silver nanoparticles by the green method. 
Int J Mol Sci 13:6639–6650
 26. Silva SML, Braga CRC, Fook MVL, Raposo CMO, Carvalho LH, Canedo EL 
(2012) Application of infrared spectroscopy to analysis of chitosan/clay 
nanocomposites. In: Infrared spectroscopy—materials science, engi-
neering and technology. InTech. http://www.intechopen.com/books/
infrared-spectroscopy-materials-science-engineering-andtechnology/
application-of-infrared-spectroscopy-to-analysis-of-chitosan-clay-nano-
composites. Accessed 1 July 2015
 27. Venkatesan J, Jayakumar R, Mohandas A, Bhatnagar I, Kim SK (2014) 
Antimicrobial activity of chitosan-carbon nanotube hydrogels. Materials 
7:3946–3955
 28. Kim UJ, Furtado CA, Liu X, Chen G, Eklund PC (2005) Raman and IR spec-
troscopy of chemically processed single-walled carbon nanotubes. J Am 
Chem Soc 127:15437–15445
Page 12 of 12Tan et al. Chemistry Central Journal  (2016) 10:81 
 29. Castillo JJ, Rindzevicius T, Novoa LV, Svendsen WE, Rozlosnik N, Boisen A, 
Escobar P, Martínez F, Castillo-León J (2013) Non-covalent conjugates of 
single-walled carbon nanotubes and folic acid for interaction with cells 
over-expressing folate receptors. J Mater Chem B 1:1475–1481
 30. O’Connell MJ, Boul P, Ericson LM, Huffman C, Wang Y, Haroz E, Kuper C, 
Tour J, Ausman KD, Smalley RE (2001) Reversible water-solubilization of 
single-walled carbon nanotubes by polymer wrapping. Chem Phys Lett 
342:265–271
 31. Weyhenmeyer R, Mascher H, Birkmayer J (1992) Study on dose-linearity of 
the pharmacokinetics of silibinin diastereomers using a new stereospe-
cific assay. Int J Clin Pharmacol Ther Toxicol 30:134–138
 32. Knop K, Hoogenboom R, Fischer D, Schubert US (2010) Poly(ethylene 
glycol) in drug delivery: pros and cons as well as potential alternatives. 
Angew Chem Int Ed 49:6288–6308
 33. Muzzalupo R, Tavano L, Cassano R, Trombino S, Cilea A, Picci N (2010) 
Colon-specific devices based on methacrylic functionalized Tween 
monomer networks: swelling studies and in vitro drug release. Eur Polym 
J 46:209–216
 34. Shieh YT, Liu GL, Wu HH, Lee CC (2007) Effects of polarity and pH on the 
solubility of acid-treated carbon nanotubes in different media. Carbon 
45:1880–1890
 35. Hussein-Al-Ali SH, Arulselvan P, Fakurazi S, Hussein MZ (2014) The in vitro 
therapeutic activity of betulinic acid nanocomposite on breast cancer 
cells (MCF-7) and normal fibroblast cell (3T3). J Mater Sci 49:8171–8182
 36. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modelling on 
drug release from controlled drug delivery systems. Acta Pol Pharm 
67:217–223
 37. Esfandiary E, Valiani V, Hashemibeni B, Moradi I, Narimani M (2014) The 
evaluation of toxicity of carbon nanotubes on the human adipose-
derived-stem cells in-vitro. Adv Biomed Res 3:40
 38. Zhang D, Yi C, Zhang J, Chen Y, Yao X, Yang M (2007) The effects of carbon 
nanotubes on the proliferation and differentiation of primary osteoblasts. 
Nanotechnology 18:475102
 39. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, 
Doyle CD, West JL, Billups WE, Ausman KD, Colvin VL (2006) Functionaliza-
tion density dependence of single-walled carbon nanotubes cytotoxicity 
in vitro. Toxicol Lett 161:135–142
 40. Zeinabad HA, Zarrabian A, Saboury AA, Alizadeh AM, Falahati M (2016) 
Interaction of single and multi wall carbon nanotubes with the biological 
systems: tau protein and PC12 cells as targets. Sc Rep 6:26508
 41. Herold DA, Rodeheaver GT, Bellamy WT, Fitton LA, Bruns DE, Edlich 
RF (1982) Toxicity of topical polyethylene glycol. Toxicol Appl Pharm 
65:329–335
 42. Beasley VR, Buck WB (1980) Acute ethylene glycol toxicosis: a review. Vet 
Hum Toxicol 22:255–263
 43. Fruijtier-Pölloth C (2005) Safety assessment on polyethylene glycols 
(PEGs) and their derivatives as used in cosmetic products. Toxicology 
214:1–38
